Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice

N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor

(2010) Douglas McHugh et al.   BMC NEUROSCIENCE

New treatment strategies in multiple sclerosis

(2010) Joanne L. Jones et al.   EXPERIMENTAL NEUROLOGY

Cannabinoids and the immune system: An overview

(2010) Radu Tanasescu et al.   IMMUNOBIOLOGY

Guide to Receptors and Channels (GRAC), 4th edition

(2009)   BRITISH JOURNAL OF PHARMACOLOGY

Update on Inflammation, Neurodegeneration, and Immunoregulation in Multiple Sclerosis

(2009) Jeffrey L. Bennett et al.   CLINICAL NEUROPHARMACOLOGY

Differential changes in GPR55 during microglial cell activation

(2009) Maciej Pietr et al.   FEBS LETTERS

Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression

(2009) Sadiye Amcaoglu Rieder et al.   IMMUNOBIOLOGY

Cannabinoids Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Inhibit the Lipopolysaccharide-activated NF-κB and Interferon-β/STAT Proinflammatory Pathways in BV-2 Microglial Cells

(2009) Ewa Kozela et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Restoring immune suppression in the multiple sclerosis brain

(2009) Nathalie Koning et al.   PROGRESS IN NEUROBIOLOGY

The Absence of the Pro-antioxidant Transcription Factor Nrf2 Exacerbates Experimental Autoimmune Encephalomyelitis

(2009) Delinda A. Johnson et al.   TOXICOLOGICAL SCIENCES

The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT)

(2008) Barbara L.F. Kaplan et al.   BIOCHEMICAL PHARMACOLOGY

A comparative study on cannabidiol-induced apoptosis in murine thymocytes and EL-4 thymoma cells

(2008) Chi-Ya Lee et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Multiple sclerosis

(2008) Alastair Compston et al.   LANCET

Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action

(2008) Antonio Waldo Zuardi   REVISTA BRASILEIRA DE PSIQUIATRIA

Cannabidiol in vivo blunts β-amyloid induced neuroinflammation by suppressing IL-1β and iNOS expression

(2007) G Esposito et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis

(2007) J. Ludovic Croxford et al.   JOURNAL OF NEUROIMMUNOLOGY

Cannabidiol arrests onset of autoimmune diabetes in NOD mice

(2007) Lola Weiss et al.   NEUROPHARMACOLOGY

Cannabidiol-induced apoptosis in primary lymphocytes is associated with oxidative stress-dependent activation of caspase-8

(2007) Hsin-Ying Wu et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY